Biotechnology company specialising in single-cell sequencing technologies and multi-omics solutions that enable researchers and clinicians to study biological systems at unprecedented resolution. The company develops advanced platforms for analysing individual cells, providing insights into cellular behaviour, disease mechanisms, and therapeutic responses across areas such as oncology, immunology, and precision medicine. By combining single-cell genomics, bioinformatics, and translational research capabilities, Singleron supports pharmaceutical companies, research institutions, and healthcare organisations in accelerating drug discovery, biomarker identification, and the development of personalised medicine approaches.